PBX-001 / PinotBio - LARVOL DELTA

‘LegoChem-Aimed-Pino’ Bio, what is the technology of the three ADC biotech companies? [ADC Development Before] Below [Google translation] (eDaily) - "...the company is conducting preclinical trials for solid cancer for the ADC candidate 'PBX-001', which is a TROP2 antibody conjugated with a self-developed toxin. The goal is for the substance to enter clinical trials in 2025."

New trial • Oncology • Solid Tumor